When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2018-12

AUTHORS

James Weatherall, William H. Polonsky, Sally Lanar, Naomi Knoble, Jonas Håkan-Bloch, Elisabeth Constam, Athena Philis-Tsimikas, Alexia Marrel

ABSTRACT

BACKGROUND: Anecdotal reports suggest that insulin degludec (IDeg) may offer unique health-related quality of life (HRQoL) benefits. As the nature of these benefits remain unclear, this study utilized qualitative research methods to investigate and elucidate the experience of "feeling better" after initiating IDeg. METHODS: Twenty adults with type 2 diabetes (T2D) who reported "feeling better" on IDeg for > 3 months participated in 90-min interviews. One focus group and nine telephone interviews were conducted at two sites in the United States (US) and one focus group was conducted in Switzerland. Patients were ≥ 18 years of age, did not take mealtime insulin, and had switched to IDeg from another basal insulin. Discussions were audio-recorded, transcribed and translated (Swiss German). Utilizing grounded theory, transcripts were analyzed by sorting quotes into concepts using thematic analysis. RESULTS: Participants' mean age was 66 years and the average duration of T2D was 17.6 years. Mean duration of IDeg use was 1.45 years. Four major factors were identified as key contributors to patients' sense of "feeling better": 1) reduced sense of diabetes as burdensome and requiring excessive attention; 2) enhanced feelings of adaptability and freedom; 3) heightened sense of security, especially regarding concerns about hypoglycemia; and 4) greater sense of physical well-being (greater energy/less fatigue). Content saturation was achieved. Generally, patients from the US sites were more focused on medical results than Swiss patients, who were more likely to identify IDeg's effect on overall HRQoL. A limitation of the study was that the population was primarily white, > 60 and otherwise healthy (no comorbid physical or mental condition). CONCLUSIONS: A group of patients with T2D, who had switched to IDeg from another basal insulin, reported HRQoL benefits which were attributed to both diabetes-specific improvements (feeling less burdened by day-to-day diabetes demands) and non-specific gains (greater energy). The conclusions may have limited transferability due to the characteristics of the sample population and further research is needed. More... »

PAGES

87

References to SciGraph publications

Identifiers

URI

http://scigraph.springernature.com/pub.10.1186/s12955-018-0883-1

DOI

http://dx.doi.org/10.1186/s12955-018-0883-1

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1103762726

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/29720273


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Aged, 80 and over", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Cross-Sectional Studies", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Diabetes Mellitus, Type 2", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Female", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Humans", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemia", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Hypoglycemic Agents", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Insulin, Long-Acting", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Male", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Middle Aged", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Qualitative Research", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Quality of Life", 
        "type": "DefinedTerm"
      }, 
      {
        "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
        "name": "Switzerland", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Novo Nordisk (United States)", 
          "id": "https://www.grid.ac/institutes/grid.452762.0", 
          "name": [
            "Novo Nordisk Inc, 800 Scudders Mill Road, Plainsboro, NJ, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Weatherall", 
        "givenName": "James", 
        "id": "sg:person.0632365763.32", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632365763.32"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "University of California, San Diego", 
          "id": "https://www.grid.ac/institutes/grid.266100.3", 
          "name": [
            "Behavioral Diabetes Institute, San Diego, CA, USA", 
            "University of California, San Diego, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Polonsky", 
        "givenName": "William H.", 
        "id": "sg:person.01216333574.96", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216333574.96"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Mapi Group, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Lanar", 
        "givenName": "Sally", 
        "id": "sg:person.012131276423.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012131276423.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Mapi Group, Boston, MA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Knoble", 
        "givenName": "Naomi", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Novo Nordisk (Denmark)", 
          "id": "https://www.grid.ac/institutes/grid.425956.9", 
          "name": [
            "Novo Nordisk A/S, Soeborg, Denmark"
          ], 
          "type": "Organization"
        }, 
        "familyName": "H\u00e5kan-Bloch", 
        "givenName": "Jonas", 
        "id": "sg:person.0604206225.72", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604206225.72"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Winterthur, Switzerland"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Constam", 
        "givenName": "Elisabeth", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Scripps Whittier Diabetes Institute", 
          "id": "https://www.grid.ac/institutes/grid.288434.1", 
          "name": [
            "Scripps Whittier Diabetes Institute, La Jolla, CA, USA"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Philis-Tsimikas", 
        "givenName": "Athena", 
        "id": "sg:person.01025507330.63", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025507330.63"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "name": [
            "Mapi Group, Lyon, France"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Marrel", 
        "givenName": "Alexia", 
        "id": "sg:person.01315153432.01", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315153432.01"
        ], 
        "type": "Person"
      }
    ], 
    "citation": [
      {
        "id": "https://doi.org/10.1111/dme.12086", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004460308"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2013.846262", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1004788363"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.12086", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1009639687"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4158/ep13287.or", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1017977948"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jdiacomp.2015.01.012", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1024371194"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1525822x05279903", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025610663"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1177/1525822x05279903", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1025610663"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3111/13696998.2011.610852", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029053775"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2011.03329.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029342910"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jdiacomp.2015.09.003", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1029846561"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/j.1464-5491.2011.03547.x", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1032167534"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/nur.4770180211", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033043652"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1002/nur.4770180211", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1033043652"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1111/dom.12032", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1036450839"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1016/j.jdiacomp.2015.08.002", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037358950"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s11136-010-9677-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1037686961", 
          "https://doi.org/10.1007/s11136-010-9677-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.2337/dc09-1348", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1043542760"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.1185/030079905x61929", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1044073761"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4239/wjd.v8.i4.120", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084888452"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4135/9781446221792.n3", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1088010841"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "datePublished": "2018-12", 
    "datePublishedReg": "2018-12-01", 
    "description": "BACKGROUND: Anecdotal reports suggest that insulin degludec (IDeg) may offer unique health-related quality of life (HRQoL) benefits. As the nature of these benefits remain unclear, this study utilized qualitative research methods to investigate and elucidate the experience of \"feeling better\" after initiating IDeg.\nMETHODS: Twenty adults with type 2 diabetes (T2D) who reported \"feeling better\" on IDeg for >\u20093\u00a0months participated in 90-min interviews. One focus group and nine telephone interviews were conducted at two sites in the United States (US) and one focus group was conducted in Switzerland. Patients were\u2009\u2265\u200918\u00a0years of age, did not take mealtime insulin, and had switched to IDeg from another basal insulin. Discussions were audio-recorded, transcribed and translated (Swiss German). Utilizing grounded theory, transcripts were analyzed by sorting quotes into concepts using thematic analysis.\nRESULTS: Participants' mean age was 66\u00a0years and the average duration of T2D was 17.6\u00a0years. Mean duration of IDeg use was 1.45\u00a0years. Four major factors were identified as key contributors to patients' sense of \"feeling better\": 1) reduced sense of diabetes as burdensome and requiring excessive attention; 2) enhanced feelings of adaptability and freedom; 3) heightened sense of security, especially regarding concerns about hypoglycemia; and 4) greater sense of physical well-being (greater energy/less fatigue). Content saturation was achieved. Generally, patients from the US sites were more focused on medical results than Swiss patients, who were more likely to identify IDeg's effect on overall HRQoL. A limitation of the study was that the population was primarily white, >\u200960 and otherwise healthy (no comorbid physical or mental condition).\nCONCLUSIONS: A group of patients with T2D, who had switched to IDeg from another basal insulin, reported HRQoL benefits which were attributed to both diabetes-specific improvements (feeling less burdened by day-to-day diabetes demands) and non-specific gains (greater energy). The conclusions may have limited transferability due to the characteristics of the sample population and further research is needed.", 
    "genre": "research_article", 
    "id": "sg:pub.10.1186/s12955-018-0883-1", 
    "inLanguage": [
      "en"
    ], 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1031326", 
        "issn": [
          "1477-7525"
        ], 
        "name": "Health and Quality of Life Outcomes", 
        "type": "Periodical"
      }, 
      {
        "issueNumber": "1", 
        "type": "PublicationIssue"
      }, 
      {
        "type": "PublicationVolume", 
        "volumeNumber": "16"
      }
    ], 
    "name": "When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation", 
    "pagination": "87", 
    "productId": [
      {
        "name": "readcube_id", 
        "type": "PropertyValue", 
        "value": [
          "45570f263ad52c909c041d3f27cedc0ccf0689b5a851ef83307e226817c614cb"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "29720273"
        ]
      }, 
      {
        "name": "nlm_unique_id", 
        "type": "PropertyValue", 
        "value": [
          "101153626"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1186/s12955-018-0883-1"
        ]
      }, 
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1103762726"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1186/s12955-018-0883-1", 
      "https://app.dimensions.ai/details/publication/pub.1103762726"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2019-04-11T09:53", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-uberresearch-data-dimensions-target-20181106-alternative/cleanup/v134/2549eaecd7973599484d7c17b260dba0a4ecb94b/merge/v9/a6c9fde33151104705d4d7ff012ea9563521a3ce/jats-lookup/v90/0000000347_0000000347/records_89793_00000003.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://link.springer.com/10.1186%2Fs12955-018-0883-1"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12955-018-0883-1'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12955-018-0883-1'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12955-018-0883-1'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12955-018-0883-1'


 

This table displays all metadata directly associated to this object as RDF triples.

244 TRIPLES      21 PREDICATES      61 URIs      35 LITERALS      23 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1186/s12955-018-0883-1 schema:about N136e000b437542928a24d37d23a2c75a
2 N13bda631a88641a3acaac7a6aec1b62a
3 N1931f6ed8d2d483a91b5a17d4b7068a7
4 N1ff264405b4143afac6e3cc08cbde741
5 N27ec848043324560811b7577c340313e
6 N67f91975974e45d3af179d2e4abc7bc9
7 Nbb2ebd779a9041108870d36f6680bd13
8 Nbdc3da333332408080338654ed2603d1
9 Ncea0af61b86c465d81ef0231666b65a5
10 Nd07bb5a09e9b473f825b34f1b6ac5317
11 Ndd194e7c4fca465088e6628d5129851d
12 Ndebc40c34a714ffa8147809313f8d83d
13 Nf917d80f16d24eeaafff669b1c02a620
14 Nfeae6f4431754a898817a79cb2012c2e
15 anzsrc-for:11
16 anzsrc-for:1103
17 schema:author N03bb383fb0b74c7cb66315a205a60291
18 schema:citation sg:pub.10.1007/s11136-010-9677-6
19 https://doi.org/10.1002/nur.4770180211
20 https://doi.org/10.1016/j.jdiacomp.2015.01.012
21 https://doi.org/10.1016/j.jdiacomp.2015.08.002
22 https://doi.org/10.1016/j.jdiacomp.2015.09.003
23 https://doi.org/10.1111/dme.12086
24 https://doi.org/10.1111/dom.12032
25 https://doi.org/10.1111/dom.12086
26 https://doi.org/10.1111/j.1464-5491.2011.03329.x
27 https://doi.org/10.1111/j.1464-5491.2011.03547.x
28 https://doi.org/10.1177/1525822x05279903
29 https://doi.org/10.1185/030079905x61929
30 https://doi.org/10.2337/dc09-1348
31 https://doi.org/10.3111/13696998.2011.610852
32 https://doi.org/10.3111/13696998.2013.846262
33 https://doi.org/10.4135/9781446221792.n3
34 https://doi.org/10.4158/ep13287.or
35 https://doi.org/10.4239/wjd.v8.i4.120
36 schema:datePublished 2018-12
37 schema:datePublishedReg 2018-12-01
38 schema:description BACKGROUND: Anecdotal reports suggest that insulin degludec (IDeg) may offer unique health-related quality of life (HRQoL) benefits. As the nature of these benefits remain unclear, this study utilized qualitative research methods to investigate and elucidate the experience of "feeling better" after initiating IDeg. METHODS: Twenty adults with type 2 diabetes (T2D) who reported "feeling better" on IDeg for > 3 months participated in 90-min interviews. One focus group and nine telephone interviews were conducted at two sites in the United States (US) and one focus group was conducted in Switzerland. Patients were ≥ 18 years of age, did not take mealtime insulin, and had switched to IDeg from another basal insulin. Discussions were audio-recorded, transcribed and translated (Swiss German). Utilizing grounded theory, transcripts were analyzed by sorting quotes into concepts using thematic analysis. RESULTS: Participants' mean age was 66 years and the average duration of T2D was 17.6 years. Mean duration of IDeg use was 1.45 years. Four major factors were identified as key contributors to patients' sense of "feeling better": 1) reduced sense of diabetes as burdensome and requiring excessive attention; 2) enhanced feelings of adaptability and freedom; 3) heightened sense of security, especially regarding concerns about hypoglycemia; and 4) greater sense of physical well-being (greater energy/less fatigue). Content saturation was achieved. Generally, patients from the US sites were more focused on medical results than Swiss patients, who were more likely to identify IDeg's effect on overall HRQoL. A limitation of the study was that the population was primarily white, > 60 and otherwise healthy (no comorbid physical or mental condition). CONCLUSIONS: A group of patients with T2D, who had switched to IDeg from another basal insulin, reported HRQoL benefits which were attributed to both diabetes-specific improvements (feeling less burdened by day-to-day diabetes demands) and non-specific gains (greater energy). The conclusions may have limited transferability due to the characteristics of the sample population and further research is needed.
39 schema:genre research_article
40 schema:inLanguage en
41 schema:isAccessibleForFree true
42 schema:isPartOf N1779725693704aafaa632b7f034298ad
43 Na724bb4d4c4d4594917e4f1ad2b04812
44 sg:journal.1031326
45 schema:name When insulin degludec enhances quality of life in patients with type 2 diabetes: a qualitative investigation
46 schema:pagination 87
47 schema:productId N1835d7fa9ce24aa4abb5abf9bc32016c
48 N2c6d835ab5d94beeb930d16a14540fbe
49 N3241640b27094a73ae1af6ef0492439e
50 N502dacedd6e649079b38cfc232db5942
51 Nb2033ec10b0e4af0b63d570e17bf66b2
52 schema:sameAs https://app.dimensions.ai/details/publication/pub.1103762726
53 https://doi.org/10.1186/s12955-018-0883-1
54 schema:sdDatePublished 2019-04-11T09:53
55 schema:sdLicense https://scigraph.springernature.com/explorer/license/
56 schema:sdPublisher N8d1c21a1c9714f9e87a6c55f481b4ddd
57 schema:url https://link.springer.com/10.1186%2Fs12955-018-0883-1
58 sgo:license sg:explorer/license/
59 sgo:sdDataset articles
60 rdf:type schema:ScholarlyArticle
61 N03bb383fb0b74c7cb66315a205a60291 rdf:first sg:person.0632365763.32
62 rdf:rest N30fdca41967247edb2866c1f2d49e271
63 N136e000b437542928a24d37d23a2c75a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
64 schema:name Quality of Life
65 rdf:type schema:DefinedTerm
66 N13bda631a88641a3acaac7a6aec1b62a schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
67 schema:name Aged
68 rdf:type schema:DefinedTerm
69 N1779725693704aafaa632b7f034298ad schema:issueNumber 1
70 rdf:type schema:PublicationIssue
71 N1835d7fa9ce24aa4abb5abf9bc32016c schema:name pubmed_id
72 schema:value 29720273
73 rdf:type schema:PropertyValue
74 N1931f6ed8d2d483a91b5a17d4b7068a7 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
75 schema:name Hypoglycemic Agents
76 rdf:type schema:DefinedTerm
77 N1ff264405b4143afac6e3cc08cbde741 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
78 schema:name Humans
79 rdf:type schema:DefinedTerm
80 N27ec848043324560811b7577c340313e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
81 schema:name Insulin, Long-Acting
82 rdf:type schema:DefinedTerm
83 N2baf2071a10f4c849a64e4fc43e69236 schema:name Mapi Group, Boston, MA, USA
84 rdf:type schema:Organization
85 N2c6d835ab5d94beeb930d16a14540fbe schema:name readcube_id
86 schema:value 45570f263ad52c909c041d3f27cedc0ccf0689b5a851ef83307e226817c614cb
87 rdf:type schema:PropertyValue
88 N30fdca41967247edb2866c1f2d49e271 rdf:first sg:person.01216333574.96
89 rdf:rest Na97a74ca698a415da4a9d1f8af71a53d
90 N3241640b27094a73ae1af6ef0492439e schema:name dimensions_id
91 schema:value pub.1103762726
92 rdf:type schema:PropertyValue
93 N375f7c3ef7704d62a7ba8d01af001183 rdf:first N77c8b550b1904157922f80b5f2bfc6db
94 rdf:rest Nb15670c2f7c54ea48d2b141e247b8fd6
95 N410e91734f3c49c886f30f898214de64 rdf:first sg:person.01315153432.01
96 rdf:rest rdf:nil
97 N477778f8fb7e4a1b886875acb124ac4d schema:name Winterthur, Switzerland
98 rdf:type schema:Organization
99 N502dacedd6e649079b38cfc232db5942 schema:name doi
100 schema:value 10.1186/s12955-018-0883-1
101 rdf:type schema:PropertyValue
102 N534b467332d2405a98f896e1ce4f512a schema:name Mapi Group, Lyon, France
103 rdf:type schema:Organization
104 N67f91975974e45d3af179d2e4abc7bc9 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
105 schema:name Male
106 rdf:type schema:DefinedTerm
107 N77c8b550b1904157922f80b5f2bfc6db schema:affiliation N2baf2071a10f4c849a64e4fc43e69236
108 schema:familyName Knoble
109 schema:givenName Naomi
110 rdf:type schema:Person
111 N8d1c21a1c9714f9e87a6c55f481b4ddd schema:name Springer Nature - SN SciGraph project
112 rdf:type schema:Organization
113 N922a2fad614e42f082c1b3d2eccf8a40 schema:name Mapi Group, Lyon, France
114 rdf:type schema:Organization
115 Na724bb4d4c4d4594917e4f1ad2b04812 schema:volumeNumber 16
116 rdf:type schema:PublicationVolume
117 Na97a74ca698a415da4a9d1f8af71a53d rdf:first sg:person.012131276423.40
118 rdf:rest N375f7c3ef7704d62a7ba8d01af001183
119 Nb15670c2f7c54ea48d2b141e247b8fd6 rdf:first sg:person.0604206225.72
120 rdf:rest Nd38cdd2721534829a4370076b1153504
121 Nb2033ec10b0e4af0b63d570e17bf66b2 schema:name nlm_unique_id
122 schema:value 101153626
123 rdf:type schema:PropertyValue
124 Nbb2ebd779a9041108870d36f6680bd13 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
125 schema:name Qualitative Research
126 rdf:type schema:DefinedTerm
127 Nbdc3da333332408080338654ed2603d1 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
128 schema:name Switzerland
129 rdf:type schema:DefinedTerm
130 Nc25fd6e89e884c73bf3762c6692750c8 rdf:first sg:person.01025507330.63
131 rdf:rest N410e91734f3c49c886f30f898214de64
132 Ncea0af61b86c465d81ef0231666b65a5 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
133 schema:name Aged, 80 and over
134 rdf:type schema:DefinedTerm
135 Nd07bb5a09e9b473f825b34f1b6ac5317 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
136 schema:name Diabetes Mellitus, Type 2
137 rdf:type schema:DefinedTerm
138 Nd37aa3f8c82b4feaa7fd38e7e82fe54d schema:affiliation N477778f8fb7e4a1b886875acb124ac4d
139 schema:familyName Constam
140 schema:givenName Elisabeth
141 rdf:type schema:Person
142 Nd38cdd2721534829a4370076b1153504 rdf:first Nd37aa3f8c82b4feaa7fd38e7e82fe54d
143 rdf:rest Nc25fd6e89e884c73bf3762c6692750c8
144 Ndd194e7c4fca465088e6628d5129851d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
145 schema:name Cross-Sectional Studies
146 rdf:type schema:DefinedTerm
147 Ndebc40c34a714ffa8147809313f8d83d schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
148 schema:name Middle Aged
149 rdf:type schema:DefinedTerm
150 Nf917d80f16d24eeaafff669b1c02a620 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
151 schema:name Female
152 rdf:type schema:DefinedTerm
153 Nfeae6f4431754a898817a79cb2012c2e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
154 schema:name Hypoglycemia
155 rdf:type schema:DefinedTerm
156 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
157 schema:name Medical and Health Sciences
158 rdf:type schema:DefinedTerm
159 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
160 schema:name Clinical Sciences
161 rdf:type schema:DefinedTerm
162 sg:journal.1031326 schema:issn 1477-7525
163 schema:name Health and Quality of Life Outcomes
164 rdf:type schema:Periodical
165 sg:person.01025507330.63 schema:affiliation https://www.grid.ac/institutes/grid.288434.1
166 schema:familyName Philis-Tsimikas
167 schema:givenName Athena
168 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01025507330.63
169 rdf:type schema:Person
170 sg:person.012131276423.40 schema:affiliation N534b467332d2405a98f896e1ce4f512a
171 schema:familyName Lanar
172 schema:givenName Sally
173 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.012131276423.40
174 rdf:type schema:Person
175 sg:person.01216333574.96 schema:affiliation https://www.grid.ac/institutes/grid.266100.3
176 schema:familyName Polonsky
177 schema:givenName William H.
178 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01216333574.96
179 rdf:type schema:Person
180 sg:person.01315153432.01 schema:affiliation N922a2fad614e42f082c1b3d2eccf8a40
181 schema:familyName Marrel
182 schema:givenName Alexia
183 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01315153432.01
184 rdf:type schema:Person
185 sg:person.0604206225.72 schema:affiliation https://www.grid.ac/institutes/grid.425956.9
186 schema:familyName Håkan-Bloch
187 schema:givenName Jonas
188 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0604206225.72
189 rdf:type schema:Person
190 sg:person.0632365763.32 schema:affiliation https://www.grid.ac/institutes/grid.452762.0
191 schema:familyName Weatherall
192 schema:givenName James
193 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0632365763.32
194 rdf:type schema:Person
195 sg:pub.10.1007/s11136-010-9677-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037686961
196 https://doi.org/10.1007/s11136-010-9677-6
197 rdf:type schema:CreativeWork
198 https://doi.org/10.1002/nur.4770180211 schema:sameAs https://app.dimensions.ai/details/publication/pub.1033043652
199 rdf:type schema:CreativeWork
200 https://doi.org/10.1016/j.jdiacomp.2015.01.012 schema:sameAs https://app.dimensions.ai/details/publication/pub.1024371194
201 rdf:type schema:CreativeWork
202 https://doi.org/10.1016/j.jdiacomp.2015.08.002 schema:sameAs https://app.dimensions.ai/details/publication/pub.1037358950
203 rdf:type schema:CreativeWork
204 https://doi.org/10.1016/j.jdiacomp.2015.09.003 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029846561
205 rdf:type schema:CreativeWork
206 https://doi.org/10.1111/dme.12086 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004460308
207 rdf:type schema:CreativeWork
208 https://doi.org/10.1111/dom.12032 schema:sameAs https://app.dimensions.ai/details/publication/pub.1036450839
209 rdf:type schema:CreativeWork
210 https://doi.org/10.1111/dom.12086 schema:sameAs https://app.dimensions.ai/details/publication/pub.1009639687
211 rdf:type schema:CreativeWork
212 https://doi.org/10.1111/j.1464-5491.2011.03329.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1029342910
213 rdf:type schema:CreativeWork
214 https://doi.org/10.1111/j.1464-5491.2011.03547.x schema:sameAs https://app.dimensions.ai/details/publication/pub.1032167534
215 rdf:type schema:CreativeWork
216 https://doi.org/10.1177/1525822x05279903 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025610663
217 rdf:type schema:CreativeWork
218 https://doi.org/10.1185/030079905x61929 schema:sameAs https://app.dimensions.ai/details/publication/pub.1044073761
219 rdf:type schema:CreativeWork
220 https://doi.org/10.2337/dc09-1348 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043542760
221 rdf:type schema:CreativeWork
222 https://doi.org/10.3111/13696998.2011.610852 schema:sameAs https://app.dimensions.ai/details/publication/pub.1029053775
223 rdf:type schema:CreativeWork
224 https://doi.org/10.3111/13696998.2013.846262 schema:sameAs https://app.dimensions.ai/details/publication/pub.1004788363
225 rdf:type schema:CreativeWork
226 https://doi.org/10.4135/9781446221792.n3 schema:sameAs https://app.dimensions.ai/details/publication/pub.1088010841
227 rdf:type schema:CreativeWork
228 https://doi.org/10.4158/ep13287.or schema:sameAs https://app.dimensions.ai/details/publication/pub.1017977948
229 rdf:type schema:CreativeWork
230 https://doi.org/10.4239/wjd.v8.i4.120 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084888452
231 rdf:type schema:CreativeWork
232 https://www.grid.ac/institutes/grid.266100.3 schema:alternateName University of California, San Diego
233 schema:name Behavioral Diabetes Institute, San Diego, CA, USA
234 University of California, San Diego, CA, USA
235 rdf:type schema:Organization
236 https://www.grid.ac/institutes/grid.288434.1 schema:alternateName Scripps Whittier Diabetes Institute
237 schema:name Scripps Whittier Diabetes Institute, La Jolla, CA, USA
238 rdf:type schema:Organization
239 https://www.grid.ac/institutes/grid.425956.9 schema:alternateName Novo Nordisk (Denmark)
240 schema:name Novo Nordisk A/S, Soeborg, Denmark
241 rdf:type schema:Organization
242 https://www.grid.ac/institutes/grid.452762.0 schema:alternateName Novo Nordisk (United States)
243 schema:name Novo Nordisk Inc, 800 Scudders Mill Road, Plainsboro, NJ, USA
244 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...